Vikram Sinai Talaulikar: New Perspectives on GLP-1 Therapies for Obesity Management
Vikram Sinai Talaulikar, Associate Specialist in Reproductive Medicine at UCLH and Hon, shared a post on LinkedIn abour a paper by Francesca Celletti et al. published in JAMA:
“The first issue of New Scientist for 2026 brings a sharp focus on to GLP-1 weight loss medications.
It suggests that weight-loss medications should get cheaper and more accessible (with expiry of semaglutide patents in many countries) and the approval of orforglipron which can be taken in a pill form. Also, there are more promising drugs on the horizon that could produce greater benefits (with more than 100 weight-loss drugs in development).
As the article notes, there are still many unanswered questions about long-term effects, what happens when you stop and the access to these agents.
The world health organisation guidelines conclude that medications alone cannot solve the global obesity burden. The availability of GLP-1 therapies should galvanise the global community to build a fair, integrated, and sustainable obesity ecosystem. Countries must ensure equitable access not only to comprehensive disease management, but also to health promotion and prevention policies and interventions targeting the general population and those at high risk.
As health professionals, we are already seeing more of our patients use GLP-1 agents and the numbers are only set to rise in future. We will have to be prepared and informed about what comes next.”
Title: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
Authors: Francesca Celletti, Jeremy Farrar, Luz De Regil
Read the full article.
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 18, 2026, 20:27Hrishikesh Pai: Rethinking Male Infertility
-
Sep 18, 2026, 20:25Eric Verdin: Wrapping Up the Reproductive Aging Summit at the Center for Healthy Aging in Women
-
Sep 18, 2026, 20:21Investigating Pregnancy Outcomes in Women with Idiopathic POI – RBMO
-
Sep 18, 2026, 20:18Sue Ritchie: Why Aren’t We Talking About Male Fertility More?
-
Sep 18, 2026, 20:13Salma Yasin: Every Day of BFS Study Week 2026 Has Been an Exceptional Learning Experience
-
Sep 18, 2026, 20:01Qingcai Wang: Over 35 and Torn Between Trying Longer and Starting IVF?
-
Sep 18, 2026, 19:58Bhumika: Can a Woman Become Pregnant Again While Already Pregnant?
-
Sep 18, 2026, 19:5215 More Experts Join the International Fertility Forum Mumbai 2026
-
Sep 18, 2026, 19:50Curious About What Happens Behind the Scenes in the Labs? – Sims IVF